MyAverix Finance
F · Healthcare
Tevogen Bio Holdings Inc. (G28)
Biotechnology
Tevogen Bio Holdings Inc. (G28) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $632,008, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for G28
Tevogen Bio Holdings Inc. (G28) — FAQ
What is Tevogen Bio Holdings Inc.'s market cap?
Tevogen Bio Holdings Inc. (G28) has a reported market cap of $632,008 (data as of 2026-03-29).
What is G28's P/E ratio?
The price-to-earnings (P/E) ratio for Tevogen Bio Holdings Inc. (G28) is 18.00 (data as of 2026-03-29).
Does Tevogen Bio Holdings Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Tevogen Bio Holdings Inc. (G28). Check the MyAverix Finance app for the latest dividend data.
What sector is Tevogen Bio Holdings Inc. in?
Tevogen Bio Holdings Inc. (G28) is classified in the Healthcare sector (Biotechnology industry).
What exchange is G28 listed on?
G28 is listed on F.
What is Tevogen Bio Holdings Inc.'s net margin?
Tevogen Bio Holdings Inc. (G28) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.